MPSlabs
About the Program
MPSlabs, a dedicated business unit of ESQlabs, develops software solutions and provides consulting services for pharmaceutical companies and research institutions working with microphysiological systems and organ-on-chips. Our mission is to enhance the predictive power of MPS and OoCs in drug testing by:
- Emulating human physiological conditions
- Translating results to in-human situations
- Assessing drug efficacy
- Early identification of potential hazards
Key Services
Our platform is built on three main pillars:
Multi-functional Scaling: Optimization of MPS and OoC system morphology and geometry for accurate replication of human physiology in vitro
Experimental Design and Operation: Tailored protocol design services for precise experiment setup and modeling of complex biological processes
Integration with ESQlabs Core: Seamless incorporation of MPS and OoC data into ESQlabs core services for enhanced translational and predictive accuracy
Recent Achievements
The program has established significant collaborations with industry leaders:
- Partnership with Bayer for reducing animal testing in consumer health industry
- Collaboration with Sanofi in advancing organ-on-chip technology
- Secured €2.5M EIC Grant for technology validation with international end-users
Impact
Our solutions support: - Reduction of animal testing in pharmaceutical research - Enhanced drug development efficiency - More accurate prediction of drug behavior - Accelerated path to clinical success
The program continues to expand its partnerships and capabilities, working with leading pharmaceutical companies and research institutions worldwide.